HopeStage
Back to all studies
Not Yet RecruitingNCT03575000

Safety of bromocriptine added to antipsychotics for blood sugar changes

About this titleRead the official source — NCT03575000
Medication studyAges 18+United StatesSchizophrenia
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria apply.

Listed locations
PittsburghSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: January 1, 2026
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
15
Sponsor
VA Pittsburgh Healthcare System
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT03575000
Official title
Show the full official title

Open-label, Flexible-dose Adjunctive Bromocriptine for Patients With Schizophrenia and Prediabetes

Recruitment & locations

Not yet recruiting

Pittsburgh

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is VA Pittsburgh Healthcare System.

Does this study involve medication?

Yes. The study involves medication, including Bromocriptine.

Who can participate?

This study is for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies